Latest / Medsolve Dynamics / Growth failure is often a result of execution issues.
Transcript
- Yoel Bakas: When oncology programs miss margin targets, leaders usually look for one problem. billing error, a volume dip. In my experience, it's almost never one problem. Margin erosion in 2026 is a compound fracture. Capital purchases that don't match utilization caps? Staffing models that have not adopted to the new technology. Service lines launched without a commercial wrapper. This is the moment where most leaders realize growth did not fail. Execution did. At Medsolve Dynamics, we do not just fix the leak. We the vessel. That's when real conversations usually start.